In a world where energy drinks have become a staple for millions seeking a quick boost to combat fatigue, a startling revelation from recent scientific research has raised significant concerns about their safety, challenging the perception of these beverages as harmless pick-me-ups. These popular
In an era where the pharmaceutical industry faces unprecedented demand for biologics, vaccines, and advanced therapies, a monumental $3.2 billion project by Fujifilm Biotechnologies in Holly Springs, North Carolina, is capturing global attention. This facility, poised to become North America’s
Pridopidine, an investigational therapy developed for Huntington's disease, recently faced a significant hurdle when the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended against its approval. This decision poses a challenge as it influences the European
In a landmark study that redefines the landscape of cancer treatment, TAF1 has emerged as a crucial factor in regulating hematopoiesis—the process of blood cell formation often disrupted in cancer. This discovery by the pioneering team at the Sylvester Comprehensive Cancer Center, spearheaded by
The versatile nature of stem cells allows them to respond dynamically to environmental and physiological stimuli, adapting their roles as needed. In the realm of regenerative medicine, the adaptability of hair follicle stem cells (HFSCs) offers unique insight into cellular responses during stress
Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process
